Ignite Creation Date:
2025-12-26 @ 4:01 PM
Ignite Modification Date:
2025-12-29 @ 4:54 AM
Study NCT ID:
NCT05991206
Status:
RECRUITING
Last Update Posted:
2023-12-27
First Post:
2023-08-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Real-World Study of Atezolizumab in Combination With Platinum-Based Doublet Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-IIIB NSCLC
Sponsor:
Hunan Province Tumor Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-25
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-06
First Submit QC Date:
None
Study First Post Date:
2023-08-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-25
Last Update Post Date:
2023-12-27
Last Update Post Date Type:
ACTUAL